{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:58:28Z","timestamp":1776704308552,"version":"3.51.2"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["643578"],"award-info":[{"award-number":["643578"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.rpth.2023.100142","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T03:47:30Z","timestamp":1680148050000},"page":"100142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hemostatic defects in congenital disorders of glycosylation"],"prefix":"10.1016","volume":"7","author":[{"given":"Tiffany","family":"Pascreau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Auditeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Borgel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2023.100142_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrm3383","article-title":"Vertebrate protein glycosylation: diversity, synthesis and function","volume":"13","author":"Moremen","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.rpth.2023.100142_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cbpa.2009.07.022","article-title":"Determination of glycosylation sites and site-specific heterogeneity in glycoproteins","volume":"13","author":"An","year":"2009","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.rpth.2023.100142_bib3","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.bbamcr.2013.04.001","article-title":"N-linked protein glycosylation in the ER","volume":"1833","author":"Aebi","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.rpth.2023.100142_bib4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tig.2018.03.002","article-title":"Perspectives on glycosylation and its congenital disorders","volume":"34","author":"Ng","year":"2018","journal-title":"Trends Genet"},{"key":"10.1016\/j.rpth.2023.100142_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ejmg.2017.10.012","article-title":"Congenital disorders of glycosylation (CDG): Quo vadis?","volume":"61","author":"P\u00e9anne","year":"2018","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.rpth.2023.100142_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.ejhg.5200470","article-title":"Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia)","volume":"8","author":"Schollen","year":"2000","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.rpth.2023.100142_bib7","first-page":"13","article-title":"The prevalence of PMM2-CDG in Estonia based on population carrier frequencies and diagnosed patients","volume":"39","author":"Vals","year":"2018","journal-title":"JIMD Rep"},{"key":"10.1016\/j.rpth.2023.100142_bib8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/jmedgenet-2017-104903","article-title":"Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature","volume":"54","author":"Schiff","year":"2017","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.rpth.2023.100142_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.21037\/atm.2018.10.45","article-title":"Congenital disorders of glycosylation","volume":"6","author":"Chang","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.rpth.2023.100142_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.braindev.2008.03.012","article-title":"Different neuroradiological findings during two stroke-like episodes in a patient with a congenital disorder of glycosylation type Ia","volume":"31","author":"Ishikawa","year":"2009","journal-title":"Brain Dev"},{"key":"10.1016\/j.rpth.2023.100142_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2003-38614","article-title":"Neurological presentation in pediatric patients with congenital disorders of glycosylation type Ia","volume":"34","author":"Miossec-Chauvet","year":"2003","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.rpth.2023.100142_bib12","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.3390\/ijms19020619","article-title":"Stroke-like episodes and cerebellar syndrome in phosphomannomutase deficiency (PMM2-CDG): evidence for hypoglycosylation-driven channelopathy","volume":"19","author":"Izquierdo-Serra","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rpth.2023.100142_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2013.02.006","article-title":"Thrombotic complications in patients with PMM2-CDG","volume":"109","author":"Linssen","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rpth.2023.100142_bib14","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/jimd.12289","article-title":"Long term outcome of MPI-CDG patients on D-mannose therapy","volume":"43","author":"Girard","year":"2020","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.rpth.2023.100142_bib15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jimd.12241","article-title":"Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation","volume":"43","author":"\u010cechov\u00e1","year":"2020","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.rpth.2023.100142_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/1098-1004(200011)16:5<386::AID-HUMU2>3.0.CO;2-Y","article-title":"Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia)","volume":"16","author":"Matthijs","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.rpth.2023.100142_bib17","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/genes12111658","article-title":"Genotype-phenotype correlations in PMM2-CDG","volume":"12","author":"Vaes","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.rpth.2023.100142_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/adc.85.3.236","article-title":"Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H\/F119L genotype","volume":"85","author":"Kjaergaard","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.rpth.2023.100142_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1023\/A:1010581613821","article-title":"Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications","volume":"24","author":"Van Geet","year":"2001","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.rpth.2023.100142_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00001721-199603000-00003","article-title":"Complex functional and structural coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome type I","volume":"7","author":"Stibler","year":"1996","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2023.100142_bib21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-0038-1650611","article-title":"Haemostatic studies in carbohydrate-deficient glycoprotein syndrome type I","volume":"76","author":"Fiumara","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100142_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ymgme.2007.11.006","article-title":"Risk assessment of acute vascular events in congenital disorder of glycosylation type Ia","volume":"93","author":"Arnoux","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rpth.2023.100142_bib23","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1111\/jth.12031","article-title":"Congenital disorder of glycosylation (PMM2-CDG) in a patient with antithrombin deficiency and severe thrombophilia","volume":"10","author":"de la Morena-Barrio","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100142_bib24","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/jth.14559","article-title":"Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficiencies","volume":"17","author":"Pascreau","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100142_bib25","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.3324\/haematol.2018.211326","article-title":"MPI-CDG with transient hypoglycosylation and antithrombin deficiency","volume":"104","author":"de la Morena-Barrio","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2023.100142_bib26","first-page":"145","article-title":"Bone dysplasia as a key feature in three patients with a novel congenital disorder of glycosylation (CDG) type II due to a deep intronic splice mutation in TMEM165","volume":"8","author":"Zeevaert","year":"2013","journal-title":"JIMD Rep"},{"key":"10.1016\/j.rpth.2023.100142_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jimd.12021","article-title":"Factor VIII and vWF deficiency in STT3A-CDG","volume":"42","author":"Chang","year":"2019","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.rpth.2023.100142_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbrc.2008.12.036","article-title":"Congenital disorder of glycosylation Ia: new differentially expressed proteins identified by 2-DE","volume":"379","author":"Richard","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.rpth.2023.100142_bib29","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/jth.13372","article-title":"Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect","volume":"14","author":"de la Morena-Barrio","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100142_bib30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0049-3848(00)00263-2","article-title":"Mutation of any site of N-linked glycosylation accelerates the in\u00a0vivo clearance of recombinant rabbit antithrombin","volume":"99","author":"Ni","year":"2000","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100142_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/(SICI)1097-0290(19970320)53:6<547::AID-BIT2>3.0.CO;2-M","article-title":"Overexpression of recombinant human antithrombin III in Chinese hamster ovary cells results in malformation and decreased secretion of recombinant protein","volume":"53","author":"Schr\u00f6der","year":"1997","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.rpth.2023.100142_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/jth.12144","article-title":"The organizing principle of the platelet glycoprotein Ib-IX-V complex","volume":"11","author":"Li","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100142_bib33","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jtha.2023.01.009","article-title":"Comprehensive analysis of platelet glycoprotein Ib\u03b1 ectodomain glycosylation","volume":"21","author":"Hollenhorst","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100142_bib34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1055\/s-0042-1744378","article-title":"N-glycosylation deficiency reduces the activation of protein C and disrupts the endothelial barrier integrity","volume":"122","author":"Pascreau","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100142_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jimd.12024","article-title":"International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: diagnosis, treatment and follow up","volume":"42","author":"Altassan","year":"2019","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.rpth.2023.100142_bib36","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41436-018-0301-4","article-title":"Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?","volume":"21","author":"Witters","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.rpth.2023.100142_bib37","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2023.100142_bib38","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel peport","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2023.100142_bib39","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2023.100142_bib40","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1111\/hae.12457","article-title":"FXI concentrate use and risk of thrombosis","volume":"20","author":"Bolton-Maggs","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2023.100142_bib41","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1179\/1607845412Y.0000000027","article-title":"Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias","volume":"17","author":"Girolami","year":"2012","journal-title":"Hematology"},{"key":"10.1016\/j.rpth.2023.100142_bib42","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ajhg.2021.04.013","article-title":"A\u00a0mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction","volume":"108","author":"Ng","year":"2021","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.rpth.2023.100142_bib43","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1182\/blood-2004-09-3509","article-title":"Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter","volume":"105","author":"Martinez-Duncker","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100142_bib44","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1212\/WNL.0b013e3182a08f53","article-title":"Intellectual disability and bleeding diathesis due to deficient CMP\u2014sialic acid transport","volume":"81","author":"Mohamed","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.rpth.2023.100142_bib45","doi-asserted-by":"crossref","first-page":"e613","DOI":"10.3324\/haematol.2018.198028","article-title":"A\u00a0mutation in the gene coding for the sialic acid transporter SLC35A1 is required for platelet life span but not proplatelet formation","volume":"103","author":"Kauskot","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2023.100142_bib46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MOH.0000000000000170","article-title":"Novel mechanisms of platelet clearance and thrombopoietin regulation","volume":"22","author":"Grozovsky","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rpth.2023.100142_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.777402","article-title":"Severe congenital thrombocytopenia characterized by decreased platelet sialylation and moderate complement activation caused by novel compound heterozygous variants in GNE","volume":"12","author":"Smolag","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2023.100142_bib48","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1055\/s-0041-1742207","article-title":"Novel GNE gene variants associated with severe congenital thrombocytopenia and platelet sialylation defect","volume":"122","author":"Zieger","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100142_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5659","article-title":"Novel compound heterozygous mutations in a GNE myopathy with congenital thrombocytopenia: a case report and literature review","volume":"10","author":"Xu","year":"2022","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.rpth.2023.100142_bib50","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2018-04-845545","article-title":"GNE variants causing autosomal recessive macrothrombocytopenia without associated muscle wasting","volume":"132","author":"Revel-Vilk","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100142_bib51","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3324\/haematol.2021.279689","article-title":"GNE-related thrombocytopenia: evidence for a mutational hotspot in the ADP\/substrate domain of the GNE bifunctional enzyme","volume":"107","author":"Bottega","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2023.100142_bib52","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1182\/bloodadvances.2021006830","article-title":"Enhanced hepatic clearance of hyposialylated platelets explains thrombocytopenia in GNE-related macrothrombocytopenia","volume":"6","author":"Noordermeer","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.100142_bib53","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.thromres.2013.12.024","article-title":"Proteomic analysis of platelet N-glycoproteins in PMM2-CDG patients","volume":"133","author":"de la Morena-Barrio","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100142_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.thromres.2019.04.010","article-title":"Multifactorial hypercoagulable state associated with a thrombotic phenotype in phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG): case report and brief review of the literature","volume":"178","author":"Lefr\u00e8re","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100142_bib55","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.2022016995","article-title":"Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis","volume":"141","author":"Marin-Quilez","year":"2023","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2023.100142_bib56","first-page":"131","article-title":"Novel GNE gene variants associated with severe congenital thrombocytopenia and platelet sialylation defect \u2013 follow up data after hematopoietic stem cell transplantation [abstract]","volume":"6","author":"Zieger","year":"2022","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923001152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923001152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:27:27Z","timestamp":1762864047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037923001152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2475037923001152"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100142","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemostatic defects in congenital disorders of glycosylation","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"100142"}}